Risk Factors for Persistent Ductus Arteriosus Patency during Indomethacin Treatment

Journal of Pediatrics

Volumn 151, Issue 6, 2007, Pages 629-634

  Chorne, Nancy ^a   Jegatheesan, Priya ^a   Lin, Emil ^b   Shi, Robert ^b   Clyman, Ronald I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; INDOMETACIN; PROSTAGLANDIN;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG MECHANISM; FATTY ACID BLOOD LEVEL; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PATENT DUCTUS ARTERIOSUS; PATHOGENESIS; PRIORITY JOURNAL; RACE DIFFERENCE; RESPIRATORY DISTRESS; RISK FACTOR;

BETAMETHASONE; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; DUCTUS ARTERIOSUS, PATENT; GESTATIONAL AGE; GLUCOCORTICOIDS; HUMANS; INDOMETHACIN; INFANT, NEWBORN; PROSTAGLANDIN ANTAGONISTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK FACTORS;

EID: 36148989172     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.05.007     Document Type: Article

References (58)

1. Schmidt B., Davis P., Moddemann D., Ohlsson A., Roberts R.S., Saigal S., et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth- weight infants. N Engl J Med 344 (2001) 1966-1972
2. Narayanan M., Cooper B., Weiss H., and Clyman R.I. Prophylactic indomethacin: factors determining permanent ductus arteriosus closure. J Pediatr 136 (2000) 330-337
3. Cotton R.B., Lindstrom D.P., and Stahlman M.T. Early prediction of symptomatic patent ductus arteriosus from perinatal risk factors: discriminant analysis. Acta Paediatr Scand 70 (1981) 723-727
4. Furzan J.A., Reisch J., Tyson J.E., Laird P., and Rosenfeld C.R. Incidence and risk factors for symptomatic patent ductus arteriosus among inborn very-low-birth-weight infants. Early Hum Dev 12 (1985) 39-48
5. Clyman R.I., Ballard P.L., Sniderman S., Ballard R.A., Roth R., Heymann M.A., et al. Prenatal administration of betamethasone for prevention of patent ductus arteriosus. J Pediatr 98 (1981) 123-126
6. Waffarn F., Siassi B., Cabal L., and Schmidt P.L. Effect of antenatal glucocorticoids on clinical closure of the ductus arteriosus. Am J Dis Child 137 (1983) 336-338
7. Heyman E., Ohlsson A., Shennan A.T., Heilbut M., and Coceani F. Closure of patent ductus arteriosus after treatment with dexamethasone. Acta Paediatr Scand 79 (1990) 698-700
8. Halliday H.L., Ehrenkranz R.A., and Doyle L.W. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev (2003) CD001146
9. Robel-Tillig E., Knupfer M., and Vogtmann C. Cardiac adaptation in small for gestational age neonates after prenatal hemodynamic disturbances. Early Hum Dev 72 (2003) 123-129
10. Itabashi K., Ohno T., and Nishida H. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin. J Pediatr 143 (2003) 203-207
11. Fowlie P.W., and Davis P.G. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev (2002) CD000174
12. Cambonie G., Guillaumont S., Luc F., Vergnes C., Milesi C., and Voisin M. Haemodynamic features during high-frequency oscillatory ventilation in preterms. Acta Paediatr 92 (2003) 1068-1073
13. Martin G.R., and Short B.L. Doppler echocardiographic evaluation of cardiac performance in infants on prolonged extracorporeal membrane oxygenation. Am J Cardiol 62 (1988) 929-934
14. Gonzalez A., Sosenko I.R., Chandar J., Hummler H., Claure N., and Bancalari E. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr 128 (1996) 470-478
15. Hammoud M.S., Elsori H.A., Hanafi E.A., Shalabi A.A., Fouda I.A., and Devarajan L.V. Incidence and risk factors associated with the patency of ductus arteriosus in preterm infants with respiratory distress syndrome in Kuwait. Saudi Med J 24 (2003) 982-985
16. Bell E.F., and Acarregui M.J. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants (Cochrane Review). Cochrane Database Syst Rev (2001) 3
17. Clyman R.I., Mauray F., Rudolph A.M., and Heymann M.A. Age-dependent sensitivity of the lamb ductus arteriosus to indomethacin and prostaglandins. J Pediatr 96 (1980) 94-98
18. Clyman R.I., Mauray F., Heymann M.A., and Roman C. Effect of gestational age on pulmonary metabolism of prostaglandin E1 and E2. Prostaglandins 21 (1981) 505-513
19. Clyman R.I., Mauray F., Roman C., Heymann M.A., Ballard P.L., Rudolph A.M., et al. Effects of antenatal glucocorticoid administration on the ductus arteriosus of preterm lambs. Am J Physiol 241 (1981) H415-H420
20. 2. J Pediatr 98 (1981) 126-128
21. Tsai M.Y., and Brown D.M. Effect of dexamethasone on fetal lung 15-hydroxy-prostaglandin dehydrogenase: possible mechanism for the prevention of patent ductus arteriosus by maternal dexamethasone therapy. Prostaglandins Leukot Med 27 (1987) 237-245
22. Shaffer C.L., Gal P., Ransom J.L., Carlos R.Q., Smith M.S., Davey A.M., et al. Effect of age and birth weight on indomethacin pharmacodynamics in neonates treated for patent ductus arteriosus. Crit Care Med 30 (2002) 343-348
23. Friedman Z., and Demers L.M. Essential fatty acids, prostaglandins, and respiratory distress syndrome of the newborn. Pediatrics 61 (1978) 341-347
24. Chorne N., Leonard C., Piecuch R., and Clyman R.I. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics 119 (2007) 1165-1174
25. Serwer G.A., Armstrong B.E., and Anderson P.A. Continuous wave Doppler ultrasonographic quantitation of patent ductus arteriosus flow. J Pediatr 100 (1982) 297-299
26. Fowlie P.W., and Davis P.G. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 88 (2003) F464-F466
27. Cotton R.B., Stahlman M.T., Berder H.W., Graham T.P., Catterton W.Z., and Kover I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr 93 (1978) 647-651
28. Kaapa P., Lanning P., and Koivisto M. Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome. Acta Paediatr Scand 72 (1983) 179-184
29. Alexander G.R., Kogan M.D., and Himes J.H. 1994-1996 U.S. singleton birth weight percentiles for gestational age by race, Hispanic origin, and gender. Matern Child Health J 3 (1999) 225-231
30. Papile L.A., Burstein J., Burstein R., and Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weight <1500 grams. J Pediatr 92 (1978) 529-534
31. Rane A., Oelz O., Frolich J.C., Seyberth H.W., Sweetman B.J., Watson J.T., et al. Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man. Clin Pharmacol Ther 23 (1978) 658-668
32. Hammerman C., Zaia W., Berger S., Strates E., and Aldousany A. Prostaglandin levels: predictors of indomethacin responsiveness. Pediatr Cardiol 7 (1986) 61-65
33. Lucas A., and Mitchell M.D. Plasma-prostaglandins in pre-term neonates before and after treatment for patient ductus arteriosus. Lancet 2 (1978) 130-132
34. Brash A.R., Hickey D.E., Graham T.P., Oates J.A., and Cotton R.B. Pharmacokinetics of indomethacin in the neonate. N Engl J Med 305 (1981) 67-72
35. Kajino H., Goldbarg S., Roman C., Liu B.M., Mauray F., Chen Y.Q., et al. Vasa vasorum hypoperfusion is responsible for medial hypoxia and anatomic remodeling in the newborn lamb ductus arteriosus. Pediatr Res 51 (2002) 228-235
36. Clyman R.I., Chan C.Y., Mauray F., Chen Y.Q., Cox W., Seidner S.R., et al. Permanent anatomic closure of the ductus arteriosus in newborn baboons: the roles of postnatal constriction, hypoxia, and gestation. Pediatr Res 45 (1999) 19-29
37. Takahashi Y., Roman C., Chemtob S., Tse M.M., Lin E., Heymann M.A., et al. Cyclooxygenase-2 inhibitors constrict the fetal lamb ductus arteriosus both in vitro and in vivo. Am J Physiol Regul Integr Comp Physiol 278 (2000) R1496-R1505
38. 2 formation in the lamb ductus arteriosus. Prostaglandins 18 (1979) 721-730
39. Clyman R.I., Hardy P., Waleh N., Chen Y.Q., Mauray F., Fouron J.-C., et al. Cyclooxygenase-2 plays a significant role in regulating the tone of the fetal lamb ductus arteriosus. Am J Physiol 276 (1999) R913-R921
40. Jegatheesan P., Ianus V., Buchh B., Yoon G., Chorne N., Lin E., et al. Higher indomethacin doses for patent ductus arteriosus closure?. PAS 2007 database (2007) In press
41. Clyman R.I., Waleh N., Black S.M., Riemer R.K., Mauray F., and Chen Y.Q. Regulation of ductus arteriosus patency by nitric oxide in fetal lambs. The role of gestation, oxygen tension and vasa vasorum. Pediatr Res 43 (1998) 633-644
42. Keller R.L., Tacy T.A., Fields S., Ofenstein J.P., Aranda J.V., and Clyman R.I. Combined treatment with a non-selective nitric oxide synthase inhibitor (L-NMMA) and indomethacin increases ductus constriction in extremely premature newborns. Pediatric Res 58 (2005) 1216-1221
43. Kajimoto H., Hashimoto K., Bonnet S.N., Haromy A., Harry G., Moudgil R., et al. Oxygen activates the rho/rho-kinase pathway and induces rhoB and ROCK-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species. A newly recognized mechanism for sustaining ductal constriction. Circulation 115 (2007) 1777-1788
44. Thebaud B., Michelakis E.D., Wu X.C., Moudgil R., Kuzyk M., Dyck J.R., et al. Oxygen-sensitive Kv channel gene transfer confers oxygen responsiveness to preterm rabbit and remodeled human ductus arteriosus: implications for infants with patent ductus arteriosus. Circulation 110 (2004) 1372-1379
45. Takami T., Momma K., and Imamura S. Increased constriction of the ductus arteriosus by dexamethasone, indomethacin, and rofecoxib in fetal rats. Circ J 69 (2005) 354-358
46. Roghair R.D., Lamb F.S., Miller Jr. F.J., Scholz T.D., and Segar J.L. Early gestation dexamethasone programs enhanced postnatal ovine coronary artery vascular reactivity. Am J Physiol Regul Integr Comp Physiol 288 (2005) R46-R53
47. Koshino Y., Hayashi T., Matsukawa S., Asazuma K., Eguchi K., Kato H., et al. Dexamethasone modulates the expression of endothelin-1 and -A receptors in A7r5 vascular smooth muscle cells. J Cardiovasc Pharmacol 32 (1998) 665-672
48. Kornel L., Prancan A.V., Kanamarlapudi N., Hynes J., and Kuzianik E. Study on the mechanisms of glucocorticoid-induced hypertension: glucocorticoids increase transmembrane Ca2+ influx in vascular smooth muscle in vivo. Endocr Res 21 (1995) 203-210
49. Hayashi T., Nakai T., and Miyabo S. Glucocorticoids increase Ca2+ uptake and [3H]dihydropyridine binding in A7r5 vascular smooth muscle cells. Am J Physiol 261 1 Pt 1 (1991) C106-C114
50. Brem A.S., Bina R.B., Mehta S., and Marshall J. Glucocorticoids inhibit the expression of calcium-dependent potassium channels in vascular smooth muscle. Mol Genet Metab 67 (1999) 53-57
51. Smith L., and Smith J.B. Regulation of sodium-calcium exchanger by glucocorticoids and growth factors in vascular smooth muscle. J Biol Chem 269 (1994) 27527-27531
52. Yoder B.A., Siler-Khodr T., Winter V.T., and Coalson J.J. High-frequency oscillatory ventilation: effects on lung function, mechanics, and airway cytokines in the immature baboon model for neonatal chronic lung disease. Am J Respir Crit Care Med 162 (2000) 1867-1876
53. Delemos R.A., Coalson J.J., Gerstmann D.R., Kuehl T.J., and Null Jr. D.M. Oxygen toxicity in the premature baboon with hyaline membrane disease. Am Rev Respir Dis 136 (1987) 677-682
54. Meredith K.S., deLemos R.A., Coalson J.J., King R.J., Gerstmann D.R., Kumar R., et al. Role of lung injury in the pathogenesis of hyaline membrane disease in premature baboons. J Appl Physiol 66 (1989) 2150-2158
55. Takata M., Abe J., Tanaka H., Kitano Y., Doi S., Kohsaka T., et al. Intraalveolar expression of tumor necrosis factor-alpha gene during conventional and high-frequency ventilation. Am J Respir Crit Care Med 156 (1997) 272-279
56. Waleh N., Seidner S., McCurnin D., Yoder B., Liu B.M., Roman C., et al. The role of monocyte-derived cells and inflammation in baboon ductus arteriosus remodeling. Pediatr Res 57 (2005) 254-262
57. Clyman R.I., Mauray F., Heymann M.A., and Roman C. Influence of increased pulmonary vascular pressures on the closure of the ductus arteriosus in newborn lambs. Pediatr Res 25 (1989) 136-142
58. Redline R.W., Wilson-Costello D., and Hack M. Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants. Pediatr Res 52 (2002) 713-719